Market revenue in 2023 | USD 265.3 million |
Market revenue in 2030 | USD 861.4 million |
Growth rate | 18.3% (CAGR from 2023 to 2030) |
Largest segment | Instruments |
Fastest growing segment | Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Consumables, Instruments, Services |
Key market players worldwide | Thermo Fisher Scientific Inc, Agilent Technologies Inc, Illumina Inc, Qiagen NV, Roche Holding AG, Macrogenics Inc, PerkinElmer, Pacific Biosciences of California Inc, BGI Group, BGC Group Inc Ordinary Shares Class A, Bio-Rad Laboratories Inc, Myriad Genetics Inc, PierianDx, Eurofins Scientific SE |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dna sequencing market will help companies and investors design strategic landscapes.
Instruments was the largest segment with a revenue share of 49.23% in 2023. Horizon Databook has segmented the Brazil dna sequencing market based on consumables, instruments, services covering the revenue growth of each sub-segment from 2018 to 2030.
Brazil DNA sequencing market is expected to continue R&D of molecular test kits using NGS to diagnose brain disorders such as autism through start-up companies such as Mendelics and Genius. Furthermore, the presence of a natural demographic ethnic variation in the region is expected to boost R&D for NGS-derived diagnostic kits and therapies for certain rare diseases.
These potential avenues for further development of NGS applications are expected to fuel the market growth in this region during the forecast period. The improving infrastructure, expanding sequencing technologies, and increasing interest of global players in this country are also driving the market.
For instance, in October 2019, Veritas Intercontinental signed an agreement with genetic testing lab Genomika, based in Brazil, to offer whole-genome and exome sequencing services in this region. A number of NGS-based research studies conducted in the country are creating demand for NGS solutions.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil dna sequencing market , including forecasts for subscribers. This country databook contains high-level insights into Brazil dna sequencing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account